HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Engelman, R. M. Articles by Das, D. K. Search for Related Content PubMed PubMed Citation Articles by Engelman, R. M. Articles by Das, D. K.

The Annals of Thoracic Surgery, Vol 52, 918-926, Copyright © 1991 by The Society of Thoracic Surgeons

ARTICLES

Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction

RM Engelman, JA Rousou, J Iyengar and DK Das
Department of Surgery, University of Connecticut School of Medicine, Farmington.

Captopril is an angiotensin-converting enzyme inhibitor that has been reported to be effective in salvaging post-ischemic reperfused myocardium by its ability to function as a free radical-scavenging agent. A study was performed in the isolated porcine-heart model evaluating the influence of pretreatment with captopril on salvage of myocardium after an induced myocardial infarction. Measurement was carried out of regional and global myocardial function, myocardial high- energy phosphate levels, creatine kinase release, malonaldehyde formation, and 6-keto-prostaglandin F1 alpha generation. In an in vitro preparation, the influence of captopril for scavenging various free radicals was evaluated. A dose-response curve was carried out using this free radical-generating system and differing levels of captopril. Results of the study demonstrate that pretreatment with captopril at a 45-mumol/L level reduced reperfusion injury in the pig heart model. This was manifested by improved cardiac performance, a reduction in creatine kinase release, and reduced malonaldehyde generation. In vitro evaluation of captopril and its free radical-scavenging ability indicated that it is a weak scavenger of superoxide anions (O2-) but behaves as a potent scavenger of hydroxyl radicals (-OH) as well as hypohalite radicals (OCl-). Based on the influence of captopril in reducing lipid peroxidation (decreased malonaldehyde formation) and its documented ability to scavenge -OH as well as OCl-, it is suggested that myocardial preservation in a postinfarction model is due primarily to its free radical-scavenging activity, primarily of the potent free radicals -OH and OCl-.

This article has been cited by other articles:

				H. L. Lazar Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient Ann. Thorac. Surg., March 1, 2005; 79(3): 1081 - 1089. [Abstract] [Full Text] [PDF]

				S. Fischer, A. A. MacLean, M. Liu, B. Kalirai, and S. Keshavjee Inhibition of angiotensin-converting enzyme by captopril: A novel approach to reduce ischemia-reperfusion injury after lung transplantation J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 573 - 580. [Abstract] [Full Text] [PDF]

				S. Greenberg, G. Chemin, I. Shapira, J. George, Y. Wollman, S. Laniado, and G. Keren Captopril and L-Arginine Have a Synergistic Cardioprotective Effect in Ischemic-Reperfusion Injury in the Isolated Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 281 - 290. [Abstract] [PDF]

				H. L. Lazar, C. Volpe, Y. Bao, S. Rivers, J. A. Vita, and J. F. Keaney Jr Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization Ann. Thorac. Surg., August 1, 1998; 66(2): 487 - 492. [Abstract] [Full Text] [PDF]

				J. Gurevitch, D. Pevni, I. Frolkis, M. Matsa, Y. Paz, R. Mohr, and V. Yakirevich Captopril in Cardioplegia and Reperfusion: Protective Effects on the Ischemic Heart Ann. Thorac. Surg., March 1, 1997; 63(3): 627 - 633. [Abstract] [Full Text]